Epilepsy Research Today is a free monthly online journal that collates and summarizes the latest research about Epilepsy, including details on symptoms, causes, treatment, drugs, information.

Volume 4 (2007), Issue 3 (March)

1. Protein kinase C activity blocks neuropeptide Y-mediated inhibition of glutamate release and contributes to excitability of the hippocampus in status epilepticus.
   FASEB J, 21(3): 671-81. [Abstract] [Full-text]
2. The ketogenic diet: one decade later.
   Pediatrics, 119(3): 535-43. [Abstract] [Full-text]
3. Postterm delivery and risk for epilepsy in childhood.
   Pediatrics, 119(3): e554-61. [Abstract] [Full-text]
4. Sex differences in modulating blood brain barrier permeability by NO in pentylenetetrazol-induced epileptic seizures.
   Life Sci, 80(14): 1274-81. [Abstract] [Full-text]
5. Epileptiformic activity induced by antidepressants in amygdala-kindled rats.
   Eur J Pharmacol, 560(1): 23-8. [Abstract] [Full-text]
6. The neurological legacy of John Russell Reynolds (1828-1896).
   J Clin Neurosci, 14(4): 309-16. [Abstract] [Full-text]
7. Toothbrushing-induced epilepsy with structural lesions in the primary somatosensory area.
   Neurology, 68(10): 769-71. [Abstract] [Full-text]
8. Women and epilepsy: review and practical recommendations.
   Expert Rev Neurother, 7(3): 289-300. [Abstract] [Full-text]
9. Mechanisms of status epilepticus: an evidence-based review.
   Curr Opin Neurol, 20(2): 213-6. [Abstract] [Full-text]
10. Prognosis of chronic and newly diagnosed epilepsy: revisiting temporal aspects.
    Curr Opin Neurol, 20(2): 208-12. [Abstract] [Full-text]
11. Temporal lobe surgery in patients with normal MRI.
    Curr Opin Neurol, 20(2): 203-7. [Abstract] [Full-text]
12. The use of SPECT and PET in routine clinical practice in epilepsy.
    Curr Opin Neurol, 20(2): 194-202. [Abstract] [Full-text]
13. The anaesthetic and intensive care of status epilepticus.
    Curr Opin Neurol, 20(2): 188-93. [Abstract] [Full-text]
14. Vaccination, seizures and 'vaccine damage'.
    Curr Opin Neurol, 20(2): 181-7. [Abstract] [Full-text]
15. Epilepsy.
    Curr Opin Neurol, 20(2): 169-74. [Abstract] [Full-text]
16. Emerging epilepsy models: insights from mice, flies, worms and fish.
    Curr Opin Neurol, 20(2): 164-8. [Abstract] [Full-text]
17. Severe mental retardation, epilepsy, anal anomalies, and distal phalangeal hypoplasia in siblings.
    Clin Dysmorphol, 16(2): 73-6. [Abstract] [Full-text]
18. Allopurinol as adjunctive therapy in intractable epilepsy: a double-blind and placebo-controlled trial.
    Arch Med Res, 38(3): 313-6. [Abstract] [Full-text]
19. Intracerebral recordings of nocturnal hyperkinetic seizures: demonstration of a longer duration of the pre-seizure sleep spindle.
    Clin Neurophysiol, 118(4): 928-39. [Abstract] [Full-text]
20. Combined spike-related functional MRI and multiple source analysis in the non-invasive spike localization of benign rolandic epilepsy.
    Clin Neurophysiol, 118(4): 901-9. [Abstract] [Full-text]
21. Small-world networks and epilepsy: graph theoretical analysis of intracerebrally recorded mesial temporal lobe seizures.
    Clin Neurophysiol, 118(4): 918-27. [Abstract] [Full-text]
22. The role of 5-HT(7) receptors in the control of seizures.
    Brain Res, 1141: 48-55. [Abstract] [Full-text]
23. Prediction of postoperative outcome with special respect to removal of hemosiderin fringe: a study in patients with cavernous haemangiomas associated with symptomatic epilepsy.
    Seizure, 16(3): 248-53. [Abstract] [Full-text]
24. Eyelid myoclonia with absences: routine EEG is sufficient to make a diagnosis.
    Seizure, 16(3): 254-60. [Abstract] [Full-text]
25. Transient epileptic opercular syndrome.
    Seizure, 16(3): 276-82. [Abstract] [Full-text]
26. Effects of valproic acid on hearing in epileptic patients.
    Int J Pediatr Otorhinolaryngol, 71(4): 611-4. [Abstract] [Full-text]
27. Lamotrigine decreases EEG synchronization in a use-dependent manner in patients with idiopathic generalized epilepsy.
    Clin Neurophysiol, 118(4): 910-7. [Abstract] [Full-text]
28. Epilepsy and seropositivity rates of Toxocara canis and Toxoplasma gondii.
    Seizure, 16(3): 233-7. [Abstract] [Full-text]
29. Correlation between scalp-recorded electroencephalographic and electrocorticographic activities during ictal period.
    Seizure, 16(3): 238-47. [Abstract] [Full-text]
30. A study of idiopathic generalised epilepsy in an Irish population.
    Seizure, 16(3): 204-10. [Abstract] [Full-text]
31. Valproate, weight gain and carbohydrate craving: a gender study.
    Seizure, 16(3): 226-32. [Abstract] [Full-text]
32. Coping strategies in epilepsy: 50 drug-resistant and 50 seizure-free patients.
    Seizure, 16(3): 211-7. [Abstract] [Full-text]
33. Psychiatric disorders in temporal lobe epilepsy patients over the first year after surgical treatment.
    Seizure, 16(3): 218-25. [Abstract] [Full-text]
34. Levetiracetam monotherapy for children and adolescents with benign rolandic seizures.
    Seizure, 16(3): 271-5. [Abstract] [Full-text]
35. Patients who develop epilepsy during extended treatment with electroconvulsive therapy.
    Seizure, 16(3): 266-70. [Abstract] [Full-text]
36. Bilateral temporal lobe epilepsy in a patient with Turner syndrome mosaicism.
    Seizure, 16(3): 261-5. [Abstract] [Full-text]
37. Clinical characteristics associated with psychosocial functioning among patients with uncomplicated epilepsy in Spain.
    Seizure, 16(3): 195-203. [Abstract] [Full-text]
38. Status epilepticus-induced somatostatinergic hilar interneuron degeneration is regulated by striatal enriched protein tyrosine phosphatase.
    J Neurosci, 27(11): 2999-3009. [Abstract] [Full-text]
39. Seizure suppression by top1 mutations in Drosophila.
    J Neurosci, 27(11): 2927-37. [Abstract] [Full-text]
40. Mutational and expression analysis of CDK1, cyclinA2 and cyclinB1 in epilepsy-associated glioneuronal lesions.
    Neuropathol Appl Neurobiol, 33(2): 152-62. [Abstract] [Full-text]
41. Non-convulsive status epilepticus in adults: clinical forms and treatment.
    Lancet Neurol, 6(4): 329-39. [Abstract] [Full-text]
42. Postictal suppression correlates with therapeutic efficacy for depression in bilateral sine and pulse wave electroconvulsive therapy.
    Psychiatry Clin Neurosci, 61(2): 168-73. [Abstract] [Full-text]
43. Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatment.
    J Neurol Neurosurg Psychiatry, 78(4): 342-9. [Abstract] [Full-text]
44. Orofacial injuries associated with prehospital management of febrile convulsion in Nigerian children.
    Dent Traumatol, 23(2): 72-5. [Abstract] [Full-text]
45. Ictal localization by source analysis of infraslow activity in DC-coupled scalp EEG recordings.
    Neuroimage, 35(2): 583-97. [Abstract] [Full-text]
46. Statistical parameters of epileptiform brain activity differentiate frontal and temporal lobe patients.
    Epilepsy Res, 74(1): 74-8. [Abstract] [Full-text]
47. Further evidence of genetic heterogeneity in families with autosomal dominant nocturnal frontal lobe epilepsy.
    Epilepsy Res, 74(1): 70-3. [Abstract] [Full-text]
48. Epilepsia Partialis Continua over last 14 years: experience from a tertiary care center from south India.
    Epilepsy Res, 74(1): 55-9. [Abstract] [Full-text]
49. Effect of novel AMPA antagonist, NS1209, on status epilepticus. An experimental study in rat.
    Epilepsy Res, 74(1): 45-54. [Abstract] [Full-text]
50. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
    Epilepsy Res, 74(1): 60-9. [Abstract] [Full-text]
51. Inhibitory networks in epilepsy-associated gangliogliomas and in the perilesional epileptic cortex.
    Epilepsy Res, 74(1): 33-44. [Abstract] [Full-text]
52. Lack of evidence of an allelic association of a functional GABRB3 exon 1a promoter polymorphism with idiopathic generalized epilepsy.
    Epilepsy Res, 74(1): 28-32. [Abstract] [Full-text]
53. Seizure prophylaxis in an animal model of epilepsy by dietary fluoxetine supplementation.
    Epilepsy Res, 74(1): 19-27. [Abstract] [Full-text]
54. Preferential neuron loss in the rat piriform cortex following pilocarpine-induced status epilepticus.
    Epilepsy Res, 74(1): 1-18. [Abstract] [Full-text]
55. Spatial relationship of source localizations in patients with focal epilepsy: Comparison of MEG and EEG with a three spherical shells and a boundary element volume conductor model.
    Hum Brain Mapp, 28(4): 315-22. [Abstract] [Full-text]
56. Pyridoxine-dependent seizures: a family phenotype that leads to severe cognitive deficits, regardless of treatment regime.
    Dev Med Child Neurol, 49(4): 300-5. [Abstract] [Full-text]
57. Linkage and association analysis of CACNG3 in childhood absence epilepsy.
    Eur J Hum Genet, 15(4): 463-72. [Abstract] [Full-text]
58. Absence seizures are reduced by the enhancement of GABA-ergic inhibition in the hippocampus in WAG/Rij rats.
    Neurosci Lett, 416(1): 17-21. [Abstract] [Full-text]
59. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.
    Lancet, 369(9566): 1016-26. [Abstract] [Full-text]
60. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.
    Lancet, 369(9566): 1000-15. [Abstract] [Full-text]
61. Deep vein thrombosis complicating severe hypernatremia, rhabdomyolysis, and acute renal failure in a patient with untreated seizure disorder.
    Clin Exp Nephrol, 11(1): 88-91. [Abstract] [Full-text]
62. Selective vulnerability of hippocampal NAAGergic neurons in experimental temporal lobe epilepsy.
    Brain Res, 1144: 219-30. [Abstract] [Full-text]
63. Gradient magnetic-field topography for dynamic changes of epileptic discharges.
    Brain Res, 1144: 175-9. [Abstract] [Full-text]
64. Neural, endocrine and electroencephalographic hyperreactivity to human contact: a diathesis-stress model of seizure susceptibility in El mice.
    Brain Res, 1144: 248-56. [Abstract] [Full-text]
65. Hippocampal seizures cause depolymerization of filamentous actin in neurons independent of acute morphological changes.
    Brain Res, 1143: 238-46. [Abstract] [Full-text]
66. Neuropeptide Y is important for basal and seizure-induced precursor cell proliferation in the hippocampus.
    Neurobiol Dis, 26(1): 174-88. [Abstract] [Full-text]
67. Gene expression changes after seizure preconditioning in the three major hippocampal cell layers.
    Neurobiol Dis, 26(1): 66-77. [Abstract] [Full-text]
68. Opinions, attitudes and practices of Australian neurologists with regard to epilepsy and driving.
    Intern Med J, 37(4): 251-7. [Abstract] [Full-text]
69. Genetic diagnosis in Lafora disease: genotype-phenotype correlations and diagnostic pitfalls.
    Neurology, 68(13): 996-1001. [Abstract] [Full-text]
70. Genetic variants in the IMPA2 gene do not confer increased risk of febrile seizures in Caucasian patients.
    Eur J Neurol, 14(4): 424-7. [Abstract] [Full-text]
71. Slowly progressive hemiparesis in childhood as a consequence of Rasmussen encephalitis without or with delayed-onset seizures.
    Eur J Neurol, 14(4): 387-90. [Abstract] [Full-text]
72. Feedforward inhibition contributes to the control of epileptiform propagation speed.
    J Neurosci, 27(13): 3383-7. [Abstract] [Full-text]
73. Focal neuronal loss, reversible subcortical focal T2 hypointensity in seizures with a nonketotic hyperglycemic hyperosmolar state.
    Neuroradiology, 49(4): 299-305. [Abstract] [Full-text]
74. Channelopathies in idiopathic epilepsy.
    Neurotherapeutics, 4(2): 295-304. [Abstract] [Full-text]
75. The long-term risk of epilepsy after febrile seizures in susceptible subgroups.
    Am J Epidemiol, 165(8): 911-8. [Abstract] [Full-text]

© 2004-2008 Epilepsy Research Today. All Rights Reserved.